Anixa Biosciences Inc
ANIX
Get informed when a big investor buys or sells
+ FollowMarket Cap$93.9M
Close$
$0.03
98.9% downside
Current Fair Value
98.9% downsideOvervalued by 98.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $93.90 Million |
|---|---|
| Enterprise Value | $92.81 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.34 |
| Beta | 0.6 |
| Outstanding Shares | 34,182,000 |
Return
| Return on Equity | -72.02% |
|---|---|
| Return on Assets | -69.14% |
| Return on Invested Capital | -81.52% |
Valuation & Multiples
| P/E Ratio | -9.05 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -8.54 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 11, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
January 6, 2027
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 53,400▼ 24.68% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.94%▲ 0.74% |
|---|---|
| Total Invested | $14.99M▲ 13.74% |
| Investors Holding | 66▲ 3.00% |
ESG Score
No data
About Anixa Biosciences Inc
CEO: Amit Kumar